TME Pharma N.V. (EPA:ALTME)
France · Delayed Price · Currency is EUR 0.1030
-0.0004 (-0.39%)
Oct 2, 2026, 5:35 PM CET
TME Pharma Market Cap
TME Pharma has a market cap or net worth of €9.69 million as of October 2, 2026. Its market cap has decreased by -4.30% in one year.
Market Cap
9.69M
Enterprise Value
10.07M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.10
ChartMarket Cap Chart
Since September 30, 2016, TME Pharma's market cap has decreased from 43.13M to 9.69M, a decrease of -77.53%. That is a compound annual growth rate of -13.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 9.69M | 57.98% |
| Dec 31, 2025 | 6.13M | -13.10% |
| Dec 31, 2024 | 7.06M | 478.85% |
| Dec 29, 2023 | 1.22M | -26.24% |
| Dec 30, 2022 | 1.65M | -90.52% |
| Dec 31, 2021 | 17.44M | -28.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GenSight Biologics | 20.49M |
| MaaT Pharma | 19.41M |
| Biophytis | 16.56M |
| Aelis Farma | 12.02M |
| Advicenne | 9.75M |
| Aton | 9.61M |
| Poxel | 8.94M |
| NFL Biosciences | 8.24M |